George N. Papaliodis, M.D.

Harvard Medical School

Assistant Professor of Ophthalmology, Department of Ophthalmology

Massachusetts Eye and Ear

Director, Immunology and Uveitis Service
Assistant Scientist

Research Summary

Research Summary

Board-certified in internal medicine and ophthalmology, Dr. Papaliodis specializes in the treatment of systemic diseases that induce ocular inflammation. He has been involved in a multiple research projects attempting to identify disease mechanisms and novel treatments for uveitis, including an investigation of LX-211 for the treatment of ocular inflammatory diseases and pulsed electromagnetic field therapy for the treatment of uveitis. He also studied serum biomarkers and genetics in ocular sarcoidosis and was an investigator in the Abbvie sponsored study obtaining FDA approval for Humira for the treatment of uveitis. In addition to establishing one of the largest ocular inflammatory disease practices in the country, he has personally outlined the teaching curriculum in the field of uveitis/ocular inflammation for the residents at Harvard Medical School.